Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS to Provide $3M for Development of New Methods to Understand the Role of Sequence Variants


The National Institutes of General Medical Sciences has set aside $3 million in fiscal year 2013 to fund the development of new experimental and computational approaches to determine the functional relevance of human DNA sequence variants.

According to a recent funding opportunity announcement, NIGMS is seeking applications that use biochemical, cellular, bioinformatic, statistical, or high-throughput methods to interpret DNA sequence variation in a well-phenotyped population. Proposed studies should use existing DNA sequence and phenotype data.

Next-gen sequencing has revealed many rare sequence variants, the institute notes, the interpretation of which will require novel strategies.

Studies have found "that everyone's genome is riddled with loss-of-function and gain-of-function mutations as well as copy variants," GWAS projects have identified variants with small effects, and non-coding regions as well as genetic background have proven important in determining phenotype.

However, there are "few strategies available" to determine which variations at a genetic locus are biologically important. Also, mechanisms by which variations at several loci work together to produce a particular phenotype need to be defined, according to the institute.

The solicitation results from a workshop entitled "Next Generation Approaches to Understanding Human Phenotypes and Genetic Diseases" that NIGMS held earlier this year, which identified barriers and strategies needed for validating the functional and clinical consequences of sequence variants.

Applications are due Feb. 17, and the earliest start date is Dec. 1, 2012. More information is available here.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.